The DOI matches its Crossref record.
Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions
Abstract
In 1988, insulin-like growth factor-binding protein-1 (IGFBP-1) became the first characterized member of a group of structurally related soluble proteins which specifically bind and modulate the actions of the IGFs. Since then, a wealth of information has accumulated regarding the physiology of this dynamic serum protein. In this review, we update our 1993 summary (Lee PDK et al. Proc Soc Exp Biol Med 204:4-29) of the status of IGFBP-1 research. The IGFBP-1 protein sequence contains 12 N-terminal and 6 C-terminal cysteine residues which are conserved in other mammalian IGFBP-1 sequences and amongst other IGFBPs; both of the cysteine-rich regions are required for optimal IGF binding. The nonconserved IGFBP-1 midregion may act as both a hinge which defines ligand binding characteristics and as a specific target for protease activity. Integrin-binding and phosphorylation sites within the IGFBP-1 sequence have functional significance in vitro, but their physiologic relevance in vivo have not been defined. The human IGFBP-1 and IGFBP-3 genes are contiguous and located in close proximity to the homeobox A (HOXA) gene cluster on chromosome 7. The other IGFBP genes, located on chromosomes 2, 12, and 17, are also associated with HOX clusters, suggesting evolutionary linkage of the IGFBP and HOX gene families. Similarities between the hlGFBP-1 and phosphoenolpyruvate kinase (PEPCK) promoters, including regions conferring insulin, glucocorticoid, and cyclic adenosine-monophosphate responses, are consistent with our previous hypothesis that IGFBP-1 is involved in regulation of glucose metabolism. The tissue-specific patterns of IGFBP-1 gene expression in liver, kidney, decidua, and ovary may be due to stimulation of IGFBP-1 transcription by hepatic nuclear factor 1 (HNF1) proteins. Clinical and basic studies of IGFBP-1 physiology have been aided by several recently developed assay methods. Numerous investigations have confirmed that insulin, via inhibition of IGFBP-1 transcription, is the primary determinant of IGFBP-1 expression both in vitro and in viva IGF-I and IGF-II also have specific inhibitory effects on IGFBP-1 expression. Glucocorticoids and cAMP stimulate IGFBP-1 transcription, but these effects are observed only in conditions of low or absent insulin effect. Other stimulants of IGFBP-1 expression include thyroid hormones and epidermal growth factor. Phorbol ester stimulation of IGFBP-1 expression can supersede the effects of insulin in vitro; however, the mechanism and in vivo correlates of this effect have not been determined. Cytokines and, perhaps, growth hormones may affect IGFBP-1 expression, perhaps by altering the regulatory actions of insulin; this effect may have important clinical relevance. IGFBP-1 expression is upregulated in liver and (nonhuman) kidney during postinjury regeneration. The IGF-inhibitory actions of IGFBP-1 has been confirmed by numerous in vitro studies and several in vivo animal investigations, including administration of recombinant IGFBP-1 and IGFBP-1 transgenic models. IGFBP-1 has been shown to inhibit somatic linear growth, weight gain, tissue growth, and glucose metabolism. Moreover, IGFBP-1 appears to be a primary determinant of free IGF-I levels in serum. Excess levels of IGFBP-1 may contribute to growth failure in intrauterine growth restriction and in pediatric chronic renal failure, while low IGFBP-1 levels are associated with obesity and with cardiovascular risk factors in insulin resistance syndromes. Serum IGFBP-1 measurements may be useful biochemical marker in these pathologic conditions. IGFBP-1 is expressed in decidualized stromal cells of the uterine endometrium and in ovarian granulosa cells. IGFBP-1, together with IGFs, insulin, ovarian steroids, cytokines, and other factors, is involved in a complex system which regulates menstrual cycles, ovulation, decidualization, blastocyst implantation, and fetal growth. Models for the role of IGFBP-1 in female reproductive physiology are presented, and evidence for pathophysiologic roles in pre-eclampsia, polycystic ovarian syndrome, and uterine malignancy are reviewed. Very recent data indicates that IGFBP-1 undergoes regulated expression in human osteoblasts. Limited information also suggests that IGFBP-1 may be present in peripheral neurons, and that serum IGFBP-1 may increase during exercise and in critical ilIness. In summary, two major roles for IGFBP-1 in normal physiology can be constructed from current data: (i) As an “endocrine” factor, IGFBP-1 regulates the bio-availability of serum IGF-I, thereby modulating IGF-mediated tissue metabolism. The dominant regulation of IGFBP-1 expression by meal-related changes in hepatic insulin concentrations provides a dynamic link to substrate availability. (ii) As an autocrine/paracrine factor, IGFBP-1 appears to play a crucial role in the female reproductive system and, in particular, the sequence of events leading from ovulation to implantation to successful fetal outcom
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Igfbp1 has been proposed as an acute regulator of IGF-1 bioactivity 35 and its elevation in association with HB treatment is unclear.”
From Akt-dependent anabolic activity of natural and synthetic brassinosteroids in rat skeletal muscle cells (2011) · cites this paper as [35]
Citations
Cited by
Sorted by citations
Items 401–500 of 536
Davies, S., Richardson, M. C., Anthony, F. W., et al. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah124 · Cited by 9
“In this regard, many authors have stressed the particular importance of IGFBP-1, which is dynamically regulated by the action of insulin (and, therefore, indirectly influenced by diet) and is generally inhibitory to IGF action (Lee et al., 1997; Fowler et al., 2000).”
BackgroundDubey, S., Perozzo, R., Scapozza, L., et al. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.009 · Cited by 8
Borai, A., Livingstone, C., Mehta, S., ZARIF, H. A., Abdelaal, F., & Ferns, G. A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.005 · Cited by 8
Gou, N., Ji, H., Wu, W., et al. (2021) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2021.100901 · Cited by 8
Sood, M., Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_33-1 · Cited by 8
Zhang, S., Zhao, Y., Hu, X., Liu, Z., Chen, X., Chen, X., & Du, J.-Z. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.025 · Cited by 8
“Furthermore, the igfbp1 gene is known to be modulated through transcriptional regulation by many factors, including insulin, glucocorticoids, cAMP, and hypoxia (Lee et al., 1997; Powell et al., 1995; Sugawara et al., 2000).”
BackgroundMicroarray Data Analysis of Mouse Neoplasia
Malarkey, D. E., Parker, J. S., Turman, C. A., et al. (2005) · Toxicologic Pathology · doi:10.1080/01926230590888315 · Cited by 8
“Genes dysregulated in the neoplasms included H19 and IGFBP1, CD63, intestinal trefoil factor 3 (Tff3), monokine induced by γ interferon (MIG), and osteopontin (Table 1).”
BackgroundInfluentialVitamin D supplementation affects the IGF system in men after acute exercise
Darr, R. L., Savage, K. J., Baker, M. H., Wilding, G. E., Raswalsky, A., Rideout, T. C., Browne, R. W., & Horvath, P. J. (2016) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2016.11.002 · Cited by 8
“Additionally, it is bound frequently to liver derived IGFBP1 and is considered to be an interim modulator of IGF1 [11].”
BackgroundZhang, R., Wang, X., Zhang, X., Zhang, J., Zhang, X., Shi, X., Crump, D., Letcher, R. J., Giesy, J. P., & Liu, C. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b04487 · Cited by 8
The insulin-like growth factor (IGF)-IGF-binding protein axis in critical illness
Baxter, R. C. (1999) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(99)80013-6 · Cited by 8
Growth hormone aggravates renal abnormalities induced by neonatal enalapril treatment
Nilsson, A. B. M., Friberg, P., B�nquist, L., et al. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1197-y · Cited by 8
Duncan, C. A. (2011) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t36t0kzt · Cited by 8
“…catabolic conditions increase levels of low molecular weight binding proteins in circulation (mammalian IGFBP-1; piscine ≤ 31 kDa IGFBPs) that sequester IGF-1 and inhibit energy-expensive growth until conditions are more favorable (e.g., with resumed feeding; Lee et al., 1997; Kelley et al., 2001).”
BackgroundContribution of insulin‑like growth factor‑1 to tendon repair (Review)
Chen, Y., Zhu, Y., Song, S., & Hu, Y. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5636 · Cited by 9
Chen, W., Lin, H., & Li, W. (2018) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2018.04.005 · Cited by 7
Cronin, K. R., Mangan, T. P., & Carew, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040994 · Cited by 7
“[78,79] Vascular-endothelial”
Insulin-like growth factor binding protein-1 in insulin resistance and cardiovascular disease
Mehta, S., Livingstone, C., Borai, A., & Ferns, G. A. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412436701 · Cited by 7
Nedić, O., Šunderić, M., Miljuš, G., et al. (2016) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2016.01.014 · Cited by 7
“IGFBP-1 in the circulation predominantly inhibits the activity of IGF-1 and the concentration of free IGF-1 seems to be primarily determined by the IGFBP-1 level.(32) Reduced IGFBP-1 at VO2max may be seen as a mechanism to redistribute IGF-1 possibly enabling it to perform insulin-like activity and assist in intra-cel…”
BackgroundComparison between 2 insulin sensitivity indexes in obese patients.
Mannucci, E., Bardini, G., Ognibene, A., & Rotella, C. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1042 · Cited by 6
Seurin, D., Froment, P., Bluet‐Pajot, M., et al. (2002) · Pediatric Research · doi:10.1203/00006450-200208000-00007 · Cited by 7
“the insulin-dependent fluctuations seen in the normal state (2).”
BackgroundMaternal Serum Insulin-Like Growth Factor Binding Protein-1 in Pregnancy at High Altitude
Krampl, E., Kametas, N. A., McAuliffe, F. M., et al. (2002) · Obstetrics and Gynecology · doi:10.1097/00006250-200204000-00016 · Cited by 7
Wilson, M., & Lackey, S. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410303 · Cited by 7
Kamoda, T., Saitoh, H., Nakahara, S., et al. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410585 · Cited by 7
Diet and Hormonal Responses: Potential Impact on Body Composition
Volek, J. S., & Sharman, M. J. (2005) · Wiley eBooks · doi:10.1002/9780470757826.ch29 · Cited by 7
IGFs in the Female Reproductive System
Giudice, L. C. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-712-3_17 · Cited by 6
Self-citationThe role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver injury
Jee, A., Sernoskie, S. C., & Uetrecht, J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae054 · Cited by 6
Tian, C., Zhang, J., Feng, P., Lin, X., Ru, X., Zhu, C., & Li, G. (2022) · Aquaculture Reports · doi:10.1016/j.aqrep.2022.101022 · Cited by 6
Li, W., Li, H., Hu, Q., Wang, L., Yin, Z., & Hu, G. (2024) · Biology of Reproduction · doi:10.1093/biolre/ioae009 · Cited by 6
“Insulin-like growth factor binding protein 1 (IGFBP1) is the first member of the IGFBPs family, which is primarily synthesized in the liver, with detectable levels found in the kidney, decidua, and ovary as well [5].”
BackgroundKey mRNAs and lncRNAs of pituitary that affect the reproduction of FecB + + small tail han sheep
Yang, J., Tang, J., He, X., Di, R., Zhang, X., Zhang, J., Guo, X., Hu, W., & Chu, M. (2024) · BMC Genomics · doi:10.1186/s12864-024-10191-8 · Cited by 6
“This process was achieved by competitively inhibiting the combination of IGF and IGFR (Insulin Like Growth Factor 1 Receptor) [49].”
MethodNindl, B. C., Ahtiainen, J. P., Gagnon, S. S., Taipale, R. S., Pierce, J. R., Martin, B. J., Beckner, M. E., Lehti, M., Häkkinen, K., & Kyröläinen, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00315 · Cited by 6
Kaneko, N., Ishikawa, T., & Nomura, K. (2023) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2023.110826 · Cited by 6
Porcellati, F., Rossetti, P., Candeloro, P., Lucidi, P., Cioli, P., Andreoli, A. M., Ghigo, E., Bolli, G. B., & Fanelli, C. G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2838 · Cited by 6
Effects of brown rice on cellular growth and metabolic changes in mice
Yang, S.-O., Wu, C., So, M.-Y., et al. (2016) · Food Research International · doi:10.1016/j.foodres.2016.03.009 · Cited by 6
“Lee, Giudice, Conover, and Powell (1997) showed that the induction of IGFBP-1 can inhibit GH/IGF-1-dependent cellular growth and differentiation in vitro (Lee et al., 1997).”
BackgroundGraffigna, M. N., Belli, S., Larrañaga, G. F. D., Fainboim, H. A., Estepo, C., Peres, S., García, N., & Levalle, O. A. (2009) · PubMed · Cited by 6
DEY, S., & LIM, H. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50009-9 · Cited by 6
IGFBP-1 protease activity and IGFBP-1 fragments in a patient with multiple myeloma
Brandt, K., Wang, J., Lundell, K., Ståhlberg, M., von Horn, H., Ehrenborg, E., Hall, K. E., Jörnvall, H., & LEWITT, M. S. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.05.002 · Cited by 6
“IGFBP-1 is secreted by liver in a highly phosphorylated form that has high IGF-I affinity and is likely to have an important endocrine function in nutrition by inhibiting the insulin-like activity of IGFs [3,4].”
The role of the IGF axis in IGFBP-1 and IGF-I induced renal enlargement in Snell dwarf mice
Kleffens, M. D.-V., Dj, L.-K., Koster, J. G., et al. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700333 · Cited by 6
“IGFBP-1, generally believed to inhibit IGF action in the circulation, has also been reported to interact with cell surfaces and enhance local IGF-I action (Jones & Clemmons 1995, Lee et al. 1997).”
BackgroundXu, H., Jin, J., Li, Y., Wu, Y., Cheng, Z., Wang, M., Ye, X., Lai, M., & Zhang, D. (2025) · Marine Biotechnology · doi:10.1007/s10126-025-10516-y · Cited by 5
“Depending on physiological and environmental conditions, IGFBPs can either enhance or inhibit IGF function (Duan et al. 1999; Maures and Duan 2002). igfbp1 , the first member identified in this family, typically suppresses IGF signaling by preventing its interaction with receptors (Lee et al. 1997).”
El-Eshmawy, M. M., Hegazy, A., & El-Baiomy, A. A. (2011) · Journal of Endocrinology and Metabolism · doi:10.4021/jem.v1i4.43 · Cited by 5
Yamaguchi, G., Habara, S., Suzuki, S., et al. (2020) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2020.110821 · Cited by 5
Insulin Action Gene Regulation
Sutherland, C. D., Brien, R. M. O., & Granner, D. K. (2007) · Springer eBooks · doi:10.1007/978-0-387-72204-7_6 · Cited by 4
Parkinson, C., Flyvbjerg, A., & Trainer, P. J. (2003) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2003.08.004 · Cited by 5
Harvie, M., Renehan, A. G., Frystyk, J., Flyvbjerg, A., Mercer, T., Malik, R., Adams, J. E., Cuzick, J. M., & Howell, A. (2010) · The Open Obesity Journal · doi:10.2174/1876823701002020063 · Cited by 5
“Specifically, circulating levels of free IGF-I, considered by many as a surrogate of tissue bio-availability, are dependent upon circulating concentrations of IGF-binding proteins (IGFBPs), chiefly IGFBP-3, with IGFBP-1 and -2 as the main acute regulators [8].”
BackgroundKo, G. T. C., Cockram, C. S., Critchley, J., Lau, M. S., & Chan, J. C. N. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1045 · Cited by 5
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_33 · Cited by 5
Role of IGFBP-3 in Human Diseases Relying on Different Cell Signaling Pathways
Naseri, N., & Mofid, M. R. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_23_23 · Cited by 6
Long-acting Insulin Analogues and Diabetic Retinopathy: A Retrospective Cohort Study
Lin, J.-C., Shau, W., & Lai, M. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.06.031 · Cited by 4
Tanaka, K., Sakai, K., Matsushima, M., 松澤, 由., Izawa, T., Kobayashi, Y., & Iwashita, M. (2017) · Growth Factors · doi:10.1080/08977194.2017.1319827 · Cited by 4
“IGFBP-1 is predominantly produced by the liver and the decidua of mothers, and by the liver of fetuses during pregnancy (Lee et al., 1993; Lee et al., 1997).”
BackgroundTransposon insertion in pmel17 rewired skin and muscle transcriptomes in Mozambique tilapia
Sun, F., Wang, L., & Yue, G. H. (2024) · Aquaculture and Fisheries · doi:10.1016/j.aaf.2023.12.002 · Cited by 3
The Status of the GH-IGF-I Axis in a Child with Psychosocial Short Stature
Saitoh, H., Kamoda, T., & Fukushima, T. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.3.439 · Cited by 4
Justová, V., Lacinová, Z., Melenovský, V., Marek, J., Holly, J. M. P., & Hass, T. (2001) · Growth Hormone & IGF Research · doi:10.1054/ghir.2001.0257 · Cited by 4
Lee, P., Lustig, R. H., Lenders, C. M., Baillargeon, J., & Wilson, D. M. (2015) · Endocrine Practice · doi:10.4158/ep15885.or · Cited by 4
Self-citationThe Insulin Growth Factor System and Nutrition in Adulthood and Aging
LEWITT, M. S., & Hall, K. E. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-795-6_9 · Cited by 4
GH administration and renal IGF-I system in arthritic rats
de Cáceres, I. I., Priego, T., Martı́n, A. I., et al. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01640-5 · Cited by 4
Zygmunt, M. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.10.959 · Cited by 4
“The regulation of IGFBP-1 gene expression by endometrium (Han and Carter, 2000) and, during pregnancy, is expressed in low to moderate abundance in the deciduaglucocorticoids and cyclic AMP is mediated by the transcrip- tion factor, HNF1, (Lee et al., 1997), which is itself regulated (Han et al., 1996).”
BackgroundRole of IGFBP‐1 in glucose regulation?
Frystyk, J. (2000) · Acta Paediatrica · doi:10.1111/j.1651-2227.2000.tb03343.x · Cited by 4
Genetic disorders in the growth hormone-IGF-I axis
Walenkamp, M. J. (2007) · Leiden Repository (Leiden University) · Cited by 4
Effective Nutritional Supplement Combinations
Cooke, M. B., & Cribb, P. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-231-1_9 · Cited by 3
Jensen, R. B., Thankamony, A., Holst, K. K., Janssen, J. A. M. J. L., Juul, A., Dunger, D. B., Poulsen, P., & Scheike, T. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0754 · Cited by 3
Arnetz, L., Hage, C., Ekberg, N. R., Alvarsson, M., Brismar, K., Norhammar, A., & Mellbin, L. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.07.009 · Cited by 3
“cortisol [11] and glucagon [12], increase transcription of IGFBP-1, but less potently than insulin inhibits it [13,14].”
BackgroundUterine stromal cell differentiationin non-decidualizing species
Johnson, G. A. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203091500.027 · Cited by 3
Menuelle, P. (1999) · Endocrinology · doi:10.1210/en.140.5.2232 · Cited by 3
Li, Z. Q., Yu, W., Xie, X., Li, P. Q., Guo, T., Zhang, W. H., An, L., & Wang, X. (2007) · Clinical and Experimental Medicine · doi:10.1007/s10238-007-0135-x · Cited by 3
Weber, M., Baričević-Jones, I., Masnikosa, R., et al. (2009) · Journal of Medical Biochemistry · doi:10.2478/v10011-008-0030-3 · Cited by 3
Diet, Exercise and Hormone Interactions on Skeletal Muscle
Volek, J. S., & Forsythe, C. E. (2006) · Hormone Research in Paediatrics · doi:10.1159/000096618 · Cited by 3
Homocysteine and insulin levels in type 2 diabetic patients.
Chan, N. N. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1041 · Cited by 3
Laboratory testing for microalbuminuria in the general community.
Harwell, T. S., McDowall, J. M., Eyler, N., Little, R. R., Helgerson, S. D., & Gohdes, D. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1028 · Cited by 3
Clinical Implications of Insulin-Like Growth Factors and Their Binding Proteins in Reproduction.
Yoshimura, Y. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.493 · Cited by 3
Are the results really different?
Reaven, G. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1040 · Cited by 3
[Glycemic control in the coronary care unit: prognostic value and new therapeutic strategies].
Madonna, R., Colella, M. E., & Caterina, R. D. (2008) · PubMed · Cited by 3
Low Anabolic Profile in Assessing a Patient’s Overall Hair Loss
Shapiro, L. J. (2015) · Hair Therapy & Transplantation · doi:10.4172/2167-0951.1000130 · Cited by 2
“Chart, we must have a basic understanding of this polypeptide [23-25].”
BackgroundSethuNarayanan, S. R. (2011) · International Journal of Human Genetics · doi:10.1080/09723757.2011.11886136 · Cited by 2
“IGFBP-1 is previously known to be a tar get gene of DBP (Babajko and Groyer 1993) involved in the regulation of glucose metabolism and fetal growth (Lee et al. 1997).”
BackgroundChanges in gene expression in SIRT3 knockout liver cells
Tao, R., LECLERC, J., Yıldız, K., Park, S., Jung, B. H., Gius, D. R., & Özden, Ö. (2015) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1408-40 · Cited by 2
“The regulation of IGFBP-1 transcription is mainly controlled by insulin under basal conditions (Heemskerk et al., 1999) and its expression is upregulated in response to a number of inflammatory conditions (Lee et al., 1997; Scharf et al., 2004).”
BackgroundLi, M., Meng, T., Peng, F., et al. (2018) · Biologia · doi:10.2478/s11756-018-0028-3 · Cited by 2
“All the 18 cysteines, involved in intradomain disulphide bond formation (Hwa et al. 1999), form a structural framework with surrounding residues to provide the functional specificity for IGF binding (Lee et al. 1997).”
InfluentialMaternal-fetal conflict — lessons from a transgene
Giudice, L. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216389 · Cited by 2
Self-citationArimoto, M., Izutsu, A., Hara, A., & Shimizu, M. (2023) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2023.111488 · Cited by 2
The IGF-IGFBP system in aerobic exercise : with focus on skeletal muscle
Berg, U. (2007) · Figshare · Cited by 1
Clinical Uses of IGF-I and IGF Binding Protein Assays
Underwood, L. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-712-3_25 · Cited by 2
The GH/IGF-1 system during surgery and catabolism : Focus on metabolism and heart function
Wallin, M. K. E. B. (2007) · Figshare · Cited by 2
Epigenetics of Diabetic Nephropathy
Gu, H. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_27-1 · Cited by 1
Microarray analysis of differentially expressed genes in preeclamptic and normal placental tissues
Ma, K., Lian, Y., Zhou, S., et al. (2014) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog16432014 · Cited by 1
The Impact of Polycystic Ovarian Syndrome on Gestational Diabetes
Aust, S., & Ott, J. (2011) · InTech eBooks · doi:10.5772/23795 · Cited by 1
“Alterations in IGFBP-1 concentrations may be due to variations in insulin secretion or hepatic insulin sensitivity, both known to be important factors in glucose regulation (Lee et al., 1997).”
BackgroundUterine disease in midlife and beyond: the menopausal transition and postmenopause
Polotsky, A. J., & Santoro, N. (2008) · CRC Press eBooks · doi:10.3109/9780203091500.054 · Cited by 2
Yamane, T., Konno, R., Iwatsuki, K., et al. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1491288 · Cited by 1
“Because IGF-I bioavailability for target cells is modulated by IGFBPs which are present in tissues at levels sufficient to alter IGF-I action [9,10], not only tissue IGF-I but also IGFBP-1 levels are important factors that determine tissue response to IGF-I.”
BackgroundEpigenetics of Diabetic Nephropathy
Gu, H. F. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_27 · Cited by 1
Harvie, M., Renehan, A. G., Frystyk, J., Flyvbjerg, A., Mercer, T., Malik, R., Adams, J. E., Cuzick, J. M., & Howell, A. (2010) · The Open Obesity Journal · doi:10.2174/1876823701002010063 · Cited by 1
Pupp, I. H. (2008) · Lund University Publications (Lund University) · Cited by 1
Endogenous Hormone Metabolism and Endometrial Cancer
Kaaks, R., & Lukanova, A. (2005) · Nutrition and disease prevention · doi:10.1201/9781420026641.ch16 · Cited by 1
Lackey, B. R., Gray, S. L., & Henricks, D. M. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1111/j.1525-1373.2000.22360.x · Cited by 1
Transposon insertion in pmel17 rewired skin and muscle transcriptomes in Mozambique tilapiaPreprint
Sun, F., Wang, L., & Yue, G. H. (2023) · Research Square · doi:10.21203/rs.3.rs-3204520/v1 · Cited by 1
Intra-ovarian Modification of FSH Action in the Human
Schipper, I. (1999) · RePub (Erasmus University Rotterdam)
Genetic analyses of type 2 diabetes related metabolic risk factors : a twin study
Souren, N. Y. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20090123ns
Furundzija, V. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12773
Colao, A., Somma, C. D., Cascella, T., Pivonello, R., Vitale, G., Grasso, L., Lombardi, G., & Savastano, S. (2008) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(08)70162-x
Lehtihet, M., Jörneskog, G., Alvarsson, M., Båvenholm, P., Katz, A., Efendić, S., Östenson, C., Kuhl, J., & Brismar, K. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.04.009
The Sirtuins in Aging and Metabolic Regulation
LaGuire, T. C., & Reaves, S. K. (2013) · Food and Nutrition Sciences · doi:10.4236/fns.2013.46086
“IGF1 levels were significantly different between male WT and transgenic mice but not between female mice and these differences coincided with differences in expression levels of IGFBP1 [61], the molecule believed to be the main acute effector of IGF1 levels [62].”
BackgroundINFLUENCE OF ALCOHOL ON SOME APPETITE- REGULATING HORMONES IN MAN
Calissendorff, J. (2008)
Endogenous hormones in the etiology of ovarian and endometrial cancers
Lukanova, A. (2004) · DiVA at Umeå University (Umeå University)
Metadata
- Authors
- Lee, P. D. K., Giudice, L. C., Conover, C. A., & Powell, D. R.
- Affiliations
- Mayo Clinic (US)
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 1997-12-01
- Volume
- 216
- Issue
- 3
- Pages
- 319-357
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2036466897
- Cited by
- 523
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 11 · 2018: 10 · 2017: 19 · 2016: 16 · 2015: 16 · 2014: 11 · 2013: 17 · 2012: 14
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- IGFBP-1, insulin-like growth factor, IGF binding, cysteine-rich region, protease cleavage, integrin binding, phosphorylation sites, IGFBP-3, chromosome 7, glucose metabolism, glucocorticoids, cyclic AMP, tissue-specific gene expression
- MeSH terms
- Amino Acid Sequence, Animals, Bone and Bones, Cartilage, Connective Tissue, Female, Gene Expression Regulation, Genitalia, Female, Genitalia, Male, Humans, Kidney, Liver, Male, Molecular Sequence Data, Organ Specificity, Substrate Specificity, Insulin-Like Growth Factor Binding Protein 1, Evolution, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review